Structural implications for selective targeting of PARPs

by Jamin D. Steffen, Jonathan R. Brody, Roger S. Armen, John Matteson Pascal
Published 2013-12-01

Metabolic Dependencies in Pancreatic Cancer

by Ali Vaziri-Gohar, Mahsa Zarei, Mahsa Zarei, Jonathan R. Brody, Jordan M. Winter, Jordan M. Winter
Published 2018-12-01

Corrigendum: Metabolic Dependencies in Pancreatic Cancer

by Ali Vaziri-Gohar, Mahsa Zarei, Mahsa Zarei, Jonathan R. Brody, Jordan M. Winter, Jordan M. Winter
Published 2019-01-01

Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure

by Tyler M. Bauer, Teena Dhir, Adam Strickland, Henry Thomsett, Austin B. Goetz, Shawnna Cannaday, Jonathan R. Brody, Michael J. Pishvaian, Charles J. Yeo
Published 2018-11-01

Precious Data: Interim Report from the Jefferson Pancreas Tumor Registry

by Theresa P. Yeo, Theresa P. Yeo, Harish Lavu, Avinoam Nevler, Avinoam Nevler, Jennifer Brumbaugh, Dominique Vicchairelli, Jordan M. Winter, Jonathan R. Brody, Charles J. Yeo
Published 2018-06-01

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

by Anteneh A. Tesfaye, Hongkun Wang, Marion L. Hartley, Aiwu Ruth He, Louis Weiner, Nina Gabelia, Lana Kapanadze, Muhammad Shezad, Jonathan R. Brody, John L. Marshall, Michael J. Pishvaian
Published 2019-05-01

pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.

by Timothy K Williams, Christina L Costantino, Nikolai A Bildzukewicz, Nathan G Richards, David W Rittenhouse, Lisa Einstein, Joseph A Cozzitorto, Judith C Keen, Abhijit Dasgupta, Myriam Gorospe, Gregory E Gonye, Charles J Yeo, Agnieszka K Witkiewicz, Jonathan R Brody
Published 2010-11-01

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen
Published 2012-01-01

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

by Jordan M Winter, Laura H Tang, David S Klimstra, Murray F Brennan, Jonathan R Brody, Flavio G Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I D'Angelica, Ronald P DeMatteo, Yuman Fong, William R Jarnagin, Eileen M O'Reilly, Peter J Allen
Published 2012-01-01

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers.

by Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, William R. Jarnagin, Eileen M. O’Reilly, Peter J. Allen
Published 2012-01-01